03:52 PM EDT, 03/22/2024 (MT Newswires) -- Health care stocks were edging down late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each down 0.1%.

The iShares Biotechnology ETF (IBB) fell 0.7%.

In corporate news, Ocugen ( OCGN ) shares surged 25%, a day after a federal appeals court upheld a lower-court decision, dismissing allegations of misleading shareholders with its statements about a prospective COVID-19 vaccine and its approvals in the US.

Cutera ( CUTR ) shares plunged almost 30%, a day after the company said its Q4 loss widened to $2.27 per diluted share from $0.40 a year earlier. Two analysts surveyed by Capital IQ expected a loss of $1.11.

Auna (AUNA) shares debuted on the New York Stock Exchange at $9.51, below the initial public offering price of $12. The stock tumbled 19% in recent trading.

Outlook Therapeutics ( OTLK ) shares soared 23% after the company's investigational ophthalmic formulation of bevacizumab to treat wet age-related macular degeneration, ONS-5010, got a positive opinion from a European Medicines Agency panel.